HomeClinical TopicsFDA approves Farydak for treatment of multiple myeloma

FDA approves Farydak for treatment of multiple myeloma

On February 23, the U.S. Food and Drug Administration (FDA) approved Farydak (panobinostat) for the treatment of patients with multiple myeloma. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content